Development and validation of a nonaqueous capillary electrophoretic method for the enantiomeric purity determination of a synthetic intermediate of new 3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans using a single-isomer anionic cyclodextrin derivative and an ionic liquid

Journal of Chromatography A

Volumn 1217, Issue 51, 2010, Pages 7949-7955

  Rousseau, Anne ^a   Florence, Xavier ^a   Pirotte, Bernard ^a   Varenne, Anne ^b   Gareil, Pierre ^b   Villemin, Didier ^c   Chiap, Patrice ^a   Crommen, Jacques ^a   Fillet, Marianne ^a   Servais, Anne Catherine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CNRS   (France)

^c 6 Bd du Maréchal Juin   (France)

Author keywords

Benzopyran derivatives; Enantiomeric purity; Ionic liquid; Nonaqueous capillary electrophoresis; Single isomer anionic cyclodextrins

Indexed keywords

CAPILLARY ELECTROPHORESIS; CYCLODEXTRINS; DRUG PRODUCTS; ELECTROLYTES; IONIC LIQUIDS;

BACK GROUND ELECTROLYTE; CAPILLARY ELECTROPHORETIC METHODS; CYCLODEXTRIN DERIVATIVES; ENANTIOMERIC PURITY; ENANTIOMERIC PURITY DETERMINATION; NON-AQUEOUS CAPILLARY ELECTROPHORESIS; SINGLE-ISOMER; SYNTHETIC INTERMEDIATES;

ENANTIOMERS;

3,4 DIHYDRO 2,2 DIMETHYL 2H 1 BENZOPYRAN DERIVATIVE; 4 AMINO 2,2 DIMETHYL 6 ETHOXYCARBONYLAMINO 3,4 DIHYDRO 2H 1 BENZOPYRAN; AMMONIUM FORMATE; BENZOPYRAN DERIVATIVE; CYCLODEXTRIN; ETHYLCHOLINE BIS(TRIFLUOROMETHYLSULFONYL)IMIDE; FORMIC ACID; HEPTAKIS(2,3 DI O METHYL 6 O SULFO) BETA CYCLODEXTRIN; IONIC LIQUID; LEVAMISOLE; METHANOL; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; ENANTIOMER; ENANTIOSELECTIVITY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STEREOISOMERISM;

EID: 78649475204     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2010.07.005     Document Type: Article

References (42)

1. FDA's policy statement for the development of new stereoisomeric drugs, 1992. http://www.fda.gov/cder/guidance/stereo.htm.
2. Aboul-Enein H.Y., Ali I. Chiral Separation by Liquid Chromatography and Related Technologies 2003, Marcel Dekker Inc., New York, USA.
3. Chirality in Drug Research, Methods and Principles in Medicinal Chemistry 33 2006, Wiley-VCH, Weinheim. E. Francotte, W. Lindner (Eds.).
4. Chankvetadze B. Capillary Electrophoresis in Chiral Analysis 1997, Wiley, Chichester.
5. Gübitz G., Schmid M.G. Electrophoresis 2007, 28:114.
6. Preinerstorfer B., Lämmerhofer M., Lindner W. Electrophoresis 2008, 30:100.
7. Ward T. Anal. Chem. 2002, 74:2863.
8. Blaschke G., Chankvetadze B. J. Chromatogr. A 2000, 875:3.
9. Lee S., Jung S. Carbohyd. Res. 2003, 338:1143.
10. Sahota R.S., Khaledi M.G. Anal. Chem. 1994, 66:1141.
11. Wang F., Khaledi M.G. Anal. Chem. 1996, 68:3460.
12. Wang F., Khaledi M.G. J. Chromatogr. B 1999, 731:187.
13. Servais A.-C., Fillet M., Abushoffa A.M., Hubert P., Crommen J. Electrophoresis 2003, 24:363.
14. Servais A.-C., Fillet M., Chiap P., Dewé W., Hubert P., Crommen J. Electrophoresis 2004, 25:2701.
15. Servais A.-C., Fillet M., Chiap P., Dewé W., Hubert P., Crommen J. J. Chromatogr. A 2005, 1068:143.
16. Rousseau A., Chiap P., Oprean R., Crommen J., Fillet M., Servais A.-C. Electrophoresis 2009, 30:2862.
17. Vaher M., Koel M., Kaljurand M. Chromatographia 2001, 53:S302.
18. François Y., Varenne A., Juillerat E., Servais A.-C., Chiap P., Gareil P. J. Chromatogr. A 2007, 1138:268.
19. Seiman A., Vaher M., Kaljurand M. J. Chromatogr. A 2008, 1189:266.
20. Rizvi S.A.A., Shamsi S.A. Anal. Chem. 2006, 78:7061.
21. Wang B., He J., Bianchi V., Shamsi S.A. Electrophoresis 2009, 30:2812.
22. Tran C.D., Mejac I. J. Chromatogr. A 2008, 1204:204.
23. François Y., Varenne A., Juillerat E., Villemin D., Gareil P. J. Chromatogr. A 2007, 1155:134.
24. Ashcroft F.M. J. Clin. Invest. 2005, 115:2047.
25. Nichols C.G. Nature 2006, 440:470.
26. Seino S. Annu. Rev. Physiol. 1999, 61:337.
27. Ashcroft F.M. Am. J. Physiol. 2007, 293:E880.
28. Miki T., Seino S. J. Mol. Cell. Cardiol. 2005, 38:917.
29. Sattiraju S., Reyes S., Kane G.C., Terzic A. Clin. Pharmacol. Ther. 2008, 83:354.
30. Kane G.C., Liu X.K., Yamada S., Olson T.M., Terzic A. J. Mol. Cell. Cardiol. 2005, 38:937.
31. Standen N.B., Quayle J.M., Davies N.W., Brayden J.E., Huang Y., Nelson M.T. Science 1989, 245:177.
32. Soundarapandian M.M., Zhong X., Peng L., Wu D., Lu Y. J. Neurochem. 2007, 103:1721.
33. Yamada K., Inagaki N. J. Mol. Cell. Cardiol. 2005, 38:945.
34. Hamilton T.C., Weir S.W., Weston A.H. Br. J. Pharmacol. 1986, 88:103.
35. Lebrun P., Antoine M.H., Devreux V., Hermann M., Herchuelz A. J. Pharmacol. Exp. Ther. 1990, 255:948.
36. Lebrun P., Arkhammar P., Antoine M.H., Nguyen Q.A., Hansen J.B., Pirotte B. Diabetologia 2000, 43:723.
37. X. Florence, Ph.D. Thesis, University of Liege, 2009.
38. Council of Europe. The European Pharmacopoeia, 6th ed., Council of Europe, Strasbourg, France, 2008.
39. Rousseau A., Gillotin F., Chiap P., Crommen J., Fillet M., Servais A.-C. Electrophoresis 2010, 31:1482.
40. Rousseau A., Chiap P., Ivanyi R., Crommen J., Fillet M., Servais A.-C. J. Chromatogr. A 2008, 1204:219.
41. Hubert P., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. STP Pharma Pratiques 2003, 13:101.
42. Boulanger B., Chiap P., Dewe W., Crommen J., Hubert P. J. Pharm. Biomed. Anal. 2003, 32:753.